{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:02:31Z","timestamp":1788307351610,"version":"build-2803163510"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10143-018-0953-1","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T03:06:14Z","timestamp":1518836774000},"page":"351-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-4087","authenticated-orcid":false,"given":"Meric A.","family":"Altinoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Ozpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Elmaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"issue":"2","key":"953_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/gyno.1998.5106","volume":"72","author":"O Abulafia","year":"1999","unstructured":"Abulafia O, Triest WE, Adcock JT, Sherer DM (1999) The effect of medroxyprogesterone acetate on angiogenesis in complex endometrial hyperplasia. Gynecol Oncol 72(2):193\u2013198. https:\/\/doi.org\/10.1006\/gyno.1998.5106","journal-title":"Gynecol Oncol"},{"issue":"1","key":"953_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1933719115597787","volume":"23","author":"WE Ackerman 4th","year":"2016","unstructured":"Ackerman WE 4th, Summerfield TL, Mesiano S, Schatz F, Lockwood CJ, Kniss DA (2016) Agonist-dependent downregulation of progesterone receptors in human cervical stromal fibroblasts. Reprod Sci 23(1):112\u2013123. https:\/\/doi.org\/10.1177\/1933719115597787","journal-title":"Reprod Sci"},{"issue":"5","key":"953_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cellbi.2006.11.013","volume":"31","author":"MA Altinoz","year":"2007","unstructured":"Altinoz MA, Bilir A, Gedikoglu G, Ozcan E, Oktem G, Muslumanoglu M (2007a) Medroxyprogesterone and tamoxifen augment anti-proliferative efficacy and reduce mitochondria-toxicity of epirubicin in FM3A tumor cells in vitro. Cell Biol Int 31(5):473\u2013481. https:\/\/doi.org\/10.1016\/j.cellbi.2006.11.013","journal-title":"Cell Biol Int"},{"issue":"6","key":"953_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0736-5748(01)00045-4","volume":"19","author":"MA Altinoz","year":"2001","unstructured":"Altinoz MA, Bilir A, Ozar E, Onar FD, Sav A (2001a) Medroxyprogesterone acetate alone or synergistic with chemotherapy suppresses colony formation and DNA synthesis in C6 glioma in vitro. Int J Dev Neurosci 19(6):541\u2013547. https:\/\/doi.org\/10.1016\/S0736-5748(01)00045-4","journal-title":"Int J Dev Neurosci"},{"issue":"10","key":"953_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1080\/00207450701540062","volume":"117","author":"MA Altinoz","year":"2007","unstructured":"Altinoz MA, Gedikoglu G, Sav A, Ozcan E, Ozdilli K, Bilir A, Del Maestro RF (2007b) Medroxyprogesterone acetate induces c6 glioma chemosensitization via antidepressant-like lysosomal phospholipidosis\/myelinosis in vitro. Int J Neurosci 117(10):1465\u20131480. https:\/\/doi.org\/10.1080\/00207450701540062","journal-title":"Int J Neurosci"},{"issue":"6","key":"953_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.canep.2013.09.017","volume":"37","author":"L Andersen","year":"2013","unstructured":"Andersen L, Friis S, Hallas J, Ravn P, Gaist D (2013) Hormone replacement therapy and risk of glioma: a nationwide nested case-control study. Cancer Epidemiol 37(6):876\u2013880. https:\/\/doi.org\/10.1016\/j.canep.2013.09.017","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"953_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/bcp.12535","volume":"79","author":"L Andersen","year":"2015","unstructured":"Andersen L, Friis S, Hallas J, Ravn P, Kristensen BW, Gaist D (2015) Hormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study. Br J Clin Pharmacol 79(4):677\u2013684. https:\/\/doi.org\/10.1111\/bcp.12535","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"953_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-014-1427-0","volume":"118","author":"GM Anic","year":"2014","unstructured":"Anic GM, Madden MH, Nabors LB, Olson JJ, LaRocca RV, Thompson ZJ, Pamnani SJ, Forsyth PA, Thompson RC, Egan KM (2014) Reproductive factors and risk of primary brain tumors in women. J Neuro-Oncol 118(2):297\u2013304. https:\/\/doi.org\/10.1007\/s11060-014-1427-0","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"953_CR9","first-page":"27","volume":"17","author":"M Assimakopoulou","year":"1998","unstructured":"Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Varakis J (1998) Does sex steroid receptor status have any prognostic or predictive significance in brain astrocytic tumors? Clin Neuropathol 17(1):27\u201334","journal-title":"Clin Neuropathol"},{"issue":"9\u201310","key":"953_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2119\/molmed.2010.00255","volume":"17","author":"F Atif","year":"2011","unstructured":"Atif F, Sayeed I, Yousuf S, Ishrat T, Hua F, Wang J, Brat DJ, Stein DG (2011) Progesterone inhibits the growth of human neuroblastoma: in vitro and in vivo evidence. Mol Med 17(9\u201310):1084\u20131094. https:\/\/doi.org\/10.2119\/molmed.2010.00255","journal-title":"Mol Med"},{"issue":"6","key":"953_CR11","doi-asserted-by":"publisher","first-page":"e0131441","DOI":"10.1371\/journal.pone.0131441","volume":"10","author":"F Atif","year":"2015","unstructured":"Atif F, Patel NR, Yousuf S, Stein DG (2015a) The synergistic effect of combination progesterone and temozolomide on human glioblastoma cells. PLoS One 10(6):e0131441. https:\/\/doi.org\/10.1371\/journal.pone.0131441","journal-title":"PLoS One"},{"key":"953_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jsbmb.2014.04.007","volume":"146","author":"F Atif","year":"2015","unstructured":"Atif F, Yousuf S, Stein DG (2015b) Anti-tumor effects of progesterone in human glioblastoma multiforme: role of PI3K\/Akt\/mTOR signaling. J Steroid Biochem Mol Biol 146:62\u201373. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.04.007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"953_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsbmb.2003.12.004","volume":"88","author":"BJ Attardi","year":"2004","unstructured":"Attardi BJ, Burgenson J, Hild SA, Reel JR (2004) In vitro antiprogestational\/ antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone. J Steroid Biochem Mol Biol 88(3):277\u2013288. https:\/\/doi.org\/10.1016\/j.jsbmb.2003.12.004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"953_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1642-431X(12)60012-6","volume":"8","author":"FW Bazer","year":"2008","unstructured":"Bazer FW, Burghardt RC, Johnson GA, Spencer TE, Wu G (2008) Interferons and progesterone for establishment and maintenance of pregnancy: interactions among novel cell signaling pathways. Reprod Biol 8(3):179\u2013211. https:\/\/doi.org\/10.1016\/S1642-431X(12)60012-6","journal-title":"Reprod Biol"},{"issue":"13","key":"953_CR15","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-06-0427","volume":"12","author":"I Benakanakere","year":"2006","unstructured":"Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM (2006) Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Clin Cancer Res 12(13):4062\u20134071. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0427","journal-title":"Clin Cancer Res"},{"issue":"7","key":"953_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/ijc.25184","volume":"127","author":"VS Benson","year":"2010","unstructured":"Benson VS, Pirie K, Green J, Bull D, Casabonne D, Reeves GK, Beral V (2010) Million women study collaborators. Hormone replacement therapy and incidence of central nervous system tumours in the million women study. Int J Cancer 127(7):1692\u20131698. https:\/\/doi.org\/10.1002\/ijc.25184","journal-title":"Int J Cancer"},{"issue":"10","key":"953_CR17","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/ijc.29274","volume":"136","author":"VS Benson","year":"2015","unstructured":"Benson VS, Kirichek O, Beral V, Green J (2015) Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis. Int J Cancer 136(10):2369\u20132377. https:\/\/doi.org\/10.1002\/ijc.29274","journal-title":"Int J Cancer"},{"issue":"12","key":"953_CR18","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1158\/0008-5472.CAN-05-4235","volume":"66","author":"CM Blakely","year":"2006","unstructured":"Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA (2006) Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 66(12):6421\u20136431. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4235","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"953_CR19","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3109\/09513590.2012.638754","volume":"27","author":"P Bouchard","year":"2011","unstructured":"Bouchard P (2011) Current and future medical treatments for menometrorrhagia during the premenopause. Gynecol Endocrinol 27(Suppl 1):1120\u20131125. https:\/\/doi.org\/10.3109\/09513590.2012.638754","journal-title":"Gynecol Endocrinol"},{"issue":"1\u20132","key":"953_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jsbmb.2008.11.009","volume":"113","author":"E Cabrera-Mu\u00f1oz","year":"2009","unstructured":"Cabrera-Mu\u00f1oz E, Gonz\u00e1lez-Arenas A, Saqui-Salces M, Camacho J, Larrea F, Garc\u00eda-Becerra R, Camacho-Arroyo I (2009) Regulation of progesterone receptor isoforms content in human astrocytoma cell lines. J Steroid Biochem Mol Biol 113(1\u20132):80\u201384. https:\/\/doi.org\/10.1016\/j.jsbmb.2008.11.009","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"953_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/BF00052425","volume":"4","author":"KP Cantor","year":"1993","unstructured":"Cantor KP, Lynch CF, Johnson D (1993) Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4(6):505\u2013511. https:\/\/doi.org\/10.1007\/BF00052425","journal-title":"Cancer Causes Control"},{"issue":"3","key":"953_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1227\/00006123-199509000-00019","volume":"37","author":"RS Carroll","year":"1995","unstructured":"Carroll RS, Zhang J, Dashner K, Sar M, Black PM (1995) Steroid hormone receptors in astrocytic neoplasms. Neurosurgery 37(3):496\u2013503. https:\/\/doi.org\/10.1227\/00006123-199509000-00019","journal-title":"Neurosurgery"},{"issue":"5","key":"953_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000226973","volume":"48","author":"PK Chakravarty","year":"1991","unstructured":"Chakravarty PK, Ghosh SK, Sinha DK (1991) Pregnancy-induced cytotoxicity of splenocytes against mammary tumor cells in rats. Oncology 48(5):425\u2013430. https:\/\/doi.org\/10.1159\/000226973","journal-title":"Oncology"},{"issue":"2","key":"953_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1005805831460","volume":"45","author":"RB Clarke","year":"1997","unstructured":"Clarke RB, Howell A, Anderson E (1997) Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat 45(2):121\u2013133. https:\/\/doi.org\/10.1023\/A:1005805831460","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"953_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0960-0760(93)90348-Z","volume":"45","author":"S Classen","year":"1993","unstructured":"Classen S, Possinger K, Pelka-Fleischer R, Wilmanns W (1993) Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells. J Steroid Biochem Mol Biol 45(4):315\u2013319. https:\/\/doi.org\/10.1016\/0960-0760(93)90348-Z","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"953_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/humupd\/4.5.539","volume":"4","author":"I Classen-Linke","year":"1998","unstructured":"Classen-Linke I, Alfer J, Hey S, Krusche CA, Kusche M, Beier HM (1998) Marker molecules of human endometrial differentiation can be hormonally regulated under in-vitro conditions as in-vivo. Hum Reprod Update 4(5):539\u2013549. https:\/\/doi.org\/10.1093\/humupd\/4.5.539","journal-title":"Hum Reprod Update"},{"issue":"29","key":"953_CR27","doi-asserted-by":"publisher","first-page":"45317","DOI":"10.18632\/oncotarget.9638","volume":"7","author":"L Communal","year":"2016","unstructured":"Communal L, Vilasco M, Hugon-Rodin J, Courtin A, Mourra N, Lahlou N, Le Guillou M, Perrault de Jotemps M, Chauvet MP, Chaouat M, Pujol P, Feunteun J, Delaloge S, Forgez P, Gompel A (2016) Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations. Oncotarget 7(29):45317\u201345330. https:\/\/doi.org\/10.18632\/oncotarget.9638","journal-title":"Oncotarget"},{"issue":"3","key":"953_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/01616412.1984.11739676","volume":"6","author":"G Concolino","year":"1984","unstructured":"Concolino G, Liccardo G, Conti C, Panfili C, Giuffre R (1984) Hormones and tumours in central nervous system (CNS): steroid receptors in primary spinal cord tumours. Neurol Res 6(3):121\u2013126. https:\/\/doi.org\/10.1080\/01616412.1984.11739676","journal-title":"Neurol Res"},{"issue":"3","key":"953_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/bcr2097","volume":"10","author":"DM Cork","year":"2008","unstructured":"Cork DM, Lennard TW, Tyson-Capper AJ (2008) Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Res 10(3):207. https:\/\/doi.org\/10.1186\/bcr2097","journal-title":"Breast Cancer Res"},{"issue":"3","key":"953_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/00003495-198835030-00001","volume":"35","author":"B Couzinet","year":"1988","unstructured":"Couzinet B, Schaison G (1988) Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control. Drugs 35(3):187\u2013191. https:\/\/doi.org\/10.2165\/00003495-198835030-00001","journal-title":"Drugs"},{"issue":"5","key":"953_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10552-011-9742-7","volume":"22","author":"A Cowppli-Bony","year":"2011","unstructured":"Cowppli-Bony A, Bouvier G, Ru\u00e9 M, Loiseau H, Vital A, Lebailly P, Fabbro-Peray P, Baldi I (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22(5):697\u2013714. https:\/\/doi.org\/10.1007\/s10552-011-9742-7","journal-title":"Cancer Causes Control"},{"issue":"1\u20132","key":"953_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mce.2009.01.004","volume":"308","author":"AR Daniel","year":"2009","unstructured":"Daniel AR, Knutson TP, Lange CA (2009) Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Mol Cell Endocrinol 308(1\u20132):47\u201352. https:\/\/doi.org\/10.1016\/j.mce.2009.01.004","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"953_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.contraception.2016.02.003","volume":"94","author":"MV Dragoman","year":"2016","unstructured":"Dragoman MV, Gaffield ME (2016) The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg\/0.65mL): a systematic review. Contraception 94(3):202\u2013215. https:\/\/doi.org\/10.1016\/j.contraception.2016.02.003","journal-title":"Contraception"},{"issue":"1","key":"953_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/emph\/eou022","volume":"2014","author":"AW D'Souza","year":"2014","unstructured":"D'Souza AW, Wagner GP (2014) Malignant cancer and invasive placentation: a case for positive pleiotropy between endometrial and malignancy phenotypes. Evol Med Public Health 2014(1):136\u2013145. https:\/\/doi.org\/10.1093\/emph\/eou022","journal-title":"Evol Med Public Health"},{"issue":"5\u20136","key":"953_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.currproblcancer.2016.05.001","volume":"40","author":"\u0130 Elmaci","year":"2016","unstructured":"Elmaci \u0130, Altinoz MA, Sav A, Yazici Z, Ozpinar A (2016) Giving another chance to mifepristone in pharmacotherapy for aggressive meningiomas\u2014a likely synergism with hydroxyurea? Curr Probl Cancer 40(5\u20136):229\u2013243. https:\/\/doi.org\/10.1016\/j.currproblcancer.2016.05.001","journal-title":"Curr Probl Cancer"},{"issue":"10","key":"953_CR36","doi-asserted-by":"publisher","first-page":"e0140795","DOI":"10.1371\/journal.pone.0140795","volume":"10","author":"N Esber","year":"2015","unstructured":"Esber N, Le Billan F, Resche-Rigon M, Loosfelt H, Lomb\u00e8s M, Chabbert-Buffet N (2015) Ulipristal acetate inhibits progesterone receptor isoform A-mediated human breast cancer proliferation and BCl2-L1 expression. PLoS One 10(10):e0140795. https:\/\/doi.org\/10.1371\/journal.pone.0140795","journal-title":"PLoS One"},{"issue":"1","key":"953_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10552-008-9220-z","volume":"20","author":"MJ Felini","year":"2009","unstructured":"Felini MJ, Olshan AF, Schroeder JC, Carozza SE, Miike R, Rice T, Wrensch M (2009) Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20(1):87\u201396. https:\/\/doi.org\/10.1007\/s10552-008-9220-z","journal-title":"Cancer Causes Control"},{"issue":"1","key":"953_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1054\/bjoc.2001.1829","volume":"85","author":"C Focan","year":"2001","unstructured":"Focan C, Beauduin M, Salamon E, de Greve J, de Wasch G, Lobelle JP, Majois F, Tagnon A, Tytgat J, van Belle S, Vandervellen R, Vindevoghel A, Adjuvant Breast Cancer Project Belgium (2001) Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial. Br J Cancer 85(1):1\u20138. https:\/\/doi.org\/10.1054\/bjoc.2001.1829","journal-title":"Br J Cancer"},{"issue":"12","key":"953_CR39","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3109\/09513590903056878","volume":"25","author":"A Gadducci","year":"2009","unstructured":"Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR (2009) Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue. Gynecol Endocrinol 25(12):807\u2013815. https:\/\/doi.org\/10.3109\/09513590903056878","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"953_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1757-2215-7-45","volume":"7","author":"CD Gamarra-Luques","year":"2014","unstructured":"Gamarra-Luques CD, Hapon MB, Goyeneche AA, Telleria CM (2014) Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity. J Ovarian Res 7(1):45. https:\/\/doi.org\/10.1186\/1757-2215-7-45","journal-title":"J Ovarian Res"},{"issue":"4","key":"953_CR41","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/bjc.1994.368","volume":"70","author":"O Gatchev","year":"1994","unstructured":"Gatchev O, R\u00e5stam L, Lindberg G, Gullberg B, T\u00f6rnberg S, Eklund GA (1994) Tumours of the central nervous system and concentration of total serum cholesterol and beta-lipoprotein in men and women. Br J Cancer 70(4):668\u2013671. https:\/\/doi.org\/10.1038\/bjc.1994.368","journal-title":"Br J Cancer"},{"issue":"3","key":"953_CR42","first-page":"139","volume":"54","author":"N Georgakulias","year":"1993","unstructured":"Georgakulias N, Singounas E, Kypriades E, Giotis J, Karvounis P (1993) Estrogen and progesterone receptors in meningiomas and gliomas. Zentralbl Neurochir 54(3):139\u2013142","journal-title":"Zentralbl Neurochir"},{"issue":"6","key":"953_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.arcmed.2016.10.002","volume":"47","author":"L Germ\u00e1n-Castel\u00e1n","year":"2016","unstructured":"Germ\u00e1n-Castel\u00e1n L, Manjarrez-Marmolejo J, Gonz\u00e1lez-Arenas A, Camacho-Arroyo I (2016) Intracellular progesterone receptor mediates the increase in glioblastoma growth induced by progesterone in the rat brain. Arch Med Res 47(6):419\u2013426. https:\/\/doi.org\/10.1016\/j.arcmed.2016.10.002","journal-title":"Arch Med Res"},{"key":"953_CR44","doi-asserted-by":"publisher","first-page":"393174","DOI":"10.1155\/2014\/393174","volume":"2014","author":"L Germ\u00e1n-Castel\u00e1n","year":"2014","unstructured":"Germ\u00e1n-Castel\u00e1n L, Manjarrez-Marmolejo J, Gonz\u00e1lez-Arenas A, Gonz\u00e1lez-Mor\u00e1n MG, Camacho-Arroyo I (2014) Progesterone induces the growth and infiltration of human astrocytoma cells implanted in the cerebral cortex of the rat. Biomed Res Int 2014:393174\u2013393178. https:\/\/doi.org\/10.1155\/2014\/393174","journal-title":"Biomed Res Int"},{"key":"953_CR45","first-page":"339","volume":"70","author":"N Gleicher","year":"1981","unstructured":"Gleicher N, Siegel I (1981) Common denominators of pregnancy and malignancy. Prog Clin Biol Res 70:339\u2013353","journal-title":"Prog Clin Biol Res"},{"issue":"2","key":"953_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12020-007-9023-0","volume":"32","author":"G Gonz\u00e1lez-Ag\u00fcero","year":"2007","unstructured":"Gonz\u00e1lez-Ag\u00fcero G, Guti\u00e9rrez AA, Gonz\u00e1lez-Espinosa D, Solano JD, Morales R, Gonz\u00e1lez-Arenas A, Cabrera-Mu\u00f1oz E, Camacho-Arroyo I (2007) Progesterone effects on cell growth of U373 and D54 human astrocytoma cell lines. Endocrine 32(2):129\u2013135. https:\/\/doi.org\/10.1007\/s12020-007-9023-0","journal-title":"Endocrine"},{"issue":"1","key":"953_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0361-9230(01)00590-1","volume":"56","author":"G Gonz\u00e1lez-Ag\u00fcero","year":"2001","unstructured":"Gonz\u00e1lez-Ag\u00fcero G, Ondarza R, Gamboa-Dom\u00ednguez A, Cerb\u00f3n MA, Camacho-Arroyo I (2001) Progesterone receptor isoforms expression pattern in human astrocytomas. Brain Res Bull 56(1):43\u201348. https:\/\/doi.org\/10.1016\/S0361-9230(01)00590-1","journal-title":"Brain Res Bull"},{"key":"953_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jsbmb.2014.09.007","volume":"144 Pt B","author":"A Gonz\u00e1lez-Arenas","year":"2014","unstructured":"Gonz\u00e1lez-Arenas A, Valadez-Cosmes P, Jim\u00e9nez-Arellano C, L\u00f3pez-S\u00e1nchez M, Camacho-Arroyo I (2014) Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R\/JAK1\/STAT6 pathway. J Steroid Biochem Mol Biol 144 Pt B:463\u2013470. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.09.007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"953_CR49","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s10637-011-9655-z","volume":"30","author":"AA Goyeneche","year":"2012","unstructured":"Goyeneche AA, Seidel EE, Telleria CM (2012) Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2. Investig New Drugs 30(3):967\u2013980. https:\/\/doi.org\/10.1007\/s10637-011-9655-z","journal-title":"Investig New Drugs"},{"issue":"11","key":"953_CR50","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1210\/mend.11.11.0006","volume":"11","author":"SD Groshong","year":"1997","unstructured":"Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB (1997) Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11(11):1593\u20131607. https:\/\/doi.org\/10.1210\/mend.11.11.0006","journal-title":"Mol Endocrinol"},{"issue":"5","key":"953_CR51","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1073\/pnas.96.5.2520","volume":"96","author":"RC Guzman","year":"1999","unstructured":"Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S (1999) Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A 96(5):2520\u20132525. https:\/\/doi.org\/10.1073\/pnas.96.5.2520","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 6","key":"953_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/rda.12029","volume":"47","author":"A G\u00fcnzel-Apel","year":"2012","unstructured":"G\u00fcnzel-Apel A, Urhausen C, Wolf K, Einspanier A, Oei C, Piechotta M (2012) Serum progesterone in pregnant bitches supplemented with progestin because of expected or suspected luteal insufficiency. Reprod Domest Anim 47(Suppl 6):55\u201360. https:\/\/doi.org\/10.1111\/rda.12029","journal-title":"Reprod Domest Anim"},{"issue":"2","key":"953_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.2910340214","volume":"34","author":"JF Haas","year":"1984","unstructured":"Haas JF (1984) Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer 34(2):229\u2013235. https:\/\/doi.org\/10.1002\/ijc.2910340214","journal-title":"Int J Cancer"},{"issue":"8","key":"953_CR54","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jnnp.49.8.874","volume":"49","author":"JF Haas","year":"1986","unstructured":"Haas JF, J\u00e4nisch W, Staneczek W (1986) Newly diagnosed primary intracranial neoplasms in pregnant women: a population-based assessment. J Neurol Neurosurg Psychiatry 49(8):874\u2013880. https:\/\/doi.org\/10.1136\/jnnp.49.8.874","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"953_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1741-7015-12-32","volume":"12","author":"CR Hagan","year":"2014","unstructured":"Hagan CR, Lange CA (2014) Molecular determinants of context-dependent progesterone receptor action in breast cancer. BMC Med 12(1):32. https:\/\/doi.org\/10.1186\/1741-7015-12-32","journal-title":"BMC Med"},{"issue":"5","key":"953_CR56","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ijc.20776","volume":"114","author":"EE Hatch","year":"2005","unstructured":"Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114(5):797\u2013805. https:\/\/doi.org\/10.1002\/ijc.20776","journal-title":"Int J Cancer"},{"issue":"4","key":"953_CR57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/026886900417388","volume":"14","author":"AE Hensiek","year":"2000","unstructured":"Hensiek AE, Kellerman AJ, Hill JT (2000) Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy. Br J Neurosurg 14(4):354\u2013356","journal-title":"Br J Neurosurg"},{"issue":"1\u20132","key":"953_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jsbmb.2012.04.005","volume":"132","author":"OT Hern\u00e1ndez-Hern\u00e1ndez","year":"2012","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez OT, Gonz\u00e1lez-Garc\u00eda TK, Camacho-Arroyo I (2012) Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines. J Steroid Biochem Mol Biol 132(1\u20132):127\u2013134. https:\/\/doi.org\/10.1016\/j.jsbmb.2012.04.005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"953_CR59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12020-009-9288-6","volume":"37","author":"OT Hern\u00e1ndez-Hern\u00e1ndez","year":"2010","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez OT, Rodr\u00edguez-Dorantes M, Gonz\u00e1lez-Arenas A, Camacho-Arroyo I (2010) Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines. Endocrine 37(1):194\u2013200. https:\/\/doi.org\/10.1007\/s12020-009-9288-6","journal-title":"Endocrine"},{"issue":"4","key":"953_CR60","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/humrep\/15.4.822","volume":"15","author":"SA Hild","year":"2000","unstructured":"Hild SA, Reel JR, Hoffman LH, Blye RP (2000) CDB-2914: anti-progestational\/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits. Hum Reprod 15(4):822\u2013829. https:\/\/doi.org\/10.1093\/humrep\/15.4.822","journal-title":"Hum Reprod"},{"key":"953_CR61","doi-asserted-by":"publisher","first-page":"8065830","DOI":"10.1155\/2016\/8065830","volume":"2016","author":"J Hlavaty","year":"2016","unstructured":"Hlavaty J, Ertl R, Miller I, Gabriel C (2016) Expression of progesterone receptor membrane component 1 (PGRMC1), progestin and adipoQ receptor 7 (PAQPR7), and plasminogen activator inhibitor 1 RNA-binding protein (PAIRBP1) in glioma spheroids in vitro. Biomed Res Int 2016:8065830\u20138065812. https:\/\/doi.org\/10.1155\/2016\/8065830","journal-title":"Biomed Res Int"},{"issue":"10","key":"953_CR62","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/1055-9965.1583.13.10","volume":"13","author":"K Huang","year":"2004","unstructured":"Huang K, Whelan EA, Ruder AM, Ward EM, Deddens JA, Davis-King KE et al (2004) Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomark Prev 13(10):1583\u20131588","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"953_CR63","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1046\/j.1365-2133.2003.05298.x","volume":"148","author":"V Hudon","year":"2003","unstructured":"Hudon V, Berthod F, Black AF, Damour O, Germain L, Auger FA (2003) A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br J Dermatol 148(6):1094\u20131104. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05298.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"953_CR64","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jad.2013.06.042","volume":"151","author":"B \u0130nce","year":"2013","unstructured":"\u0130nce B, Guloksuz S, Alt\u0131nba\u015f K, Oral ET, Alpkan LR, Altinoz MA (2013) Minor hemoglobins HbA2 and HbF associate with disease severity in bipolar disorder with a likely protective role of HbA2 against post-partum episodes. J Affect Disord 151(1):405\u2013408. https:\/\/doi.org\/10.1016\/j.jad.2013.06.042","journal-title":"J Affect Disord"},{"issue":"11","key":"953_CR65","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1210\/jc.2002-012096","volume":"87","author":"T Inoue","year":"2002","unstructured":"Inoue T, Akahira J, Suzuki T, Darnel AD, Kaneko C, Takahashi K, Hatori M, Shirane R, Kumabe T, Kurokawa Y, Satomi S, Sasano H (2002) Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab 87(11):5325\u20135331. https:\/\/doi.org\/10.1210\/jc.2002-012096","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"953_CR66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF01809555","volume":"80","author":"J J\u00e4\u00e4skel\u00e4inen","year":"1986","unstructured":"J\u00e4\u00e4skel\u00e4inen J, Laasonen E, K\u00e4rkk\u00e4inen J, Haltia M, Troupp H (1986) Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases. Acta Neurochir 80(1\u20132):35\u201341. https:\/\/doi.org\/10.1007\/BF01809555","journal-title":"Acta Neurochir"},{"issue":"10","key":"953_CR67","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1158\/1055-9965.EPI-10-0658","volume":"19","author":"GC Kabat","year":"2010","unstructured":"Kabat GC, Etgen AM, Rohan TE (2010) Do steroid hormones play a role in the etiology of glioma? Cancer Epidemiol Biomark Prev 19(10):2421\u20132427. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-0658","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"953_CR68","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ijc.25413","volume":"128","author":"GC Kabat","year":"2011","unstructured":"Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE (2011) Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP diet and health study. Int J Cancer 128(4):944\u2013950. https:\/\/doi.org\/10.1002\/ijc.25413","journal-title":"Int J Cancer"},{"key":"953_CR69","unstructured":"Khalid H, Shibata S, Kishikawa M, Yasunaga A, Iseki M, Hiura T (1997) Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer 80(11):2133\u20132140. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19971201)80:11<2133::AID-CNCR13>3.0.CO;2-#"},{"issue":"2","key":"953_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF02966915","volume":"6","author":"H Koyama","year":"1999","unstructured":"Koyama H (1999) Adjuvant therapy with high-dose medroxyprogesterone acetate for operable breast cancer. Breast Cancer 6(2):99\u2013107. https:\/\/doi.org\/10.1007\/BF02966915","journal-title":"Breast Cancer"},{"issue":"8","key":"953_CR71","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10552-014-0400-8","volume":"25","author":"B Krishnamachari","year":"2014","unstructured":"Krishnamachari B, Il\u2019yasova D, Scheurer ME, Bondy ML, Wrensch M, Davis FG (2014) A pooled multisite analysis of the effects of female reproductive hormones on glioma risk. Cancer Causes Control 25(8):1007\u20131013. https:\/\/doi.org\/10.1007\/s10552-014-0400-8","journal-title":"Cancer Causes Control"},{"issue":"Suppl 1","key":"953_CR72","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/13697137.2013.768806","volume":"16","author":"H Kuhl","year":"2013","unstructured":"Kuhl H, Schneider HP (2013) Progesterone\u2014promoter or inhibitor of breast cancer. Climacteric 16(Suppl 1):54\u201368. https:\/\/doi.org\/10.3109\/13697137.2013.768806","journal-title":"Climacteric"},{"issue":"3","key":"953_CR73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<389::AID-IJC2>3.0.CO;2-L","volume":"72","author":"M Lambe","year":"1997","unstructured":"Lambe M, Coogan P, Baron J (1997) Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 72(3):389\u2013393. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19970729)72:3<389::AID-IJC2>3.0.CO;2-L","journal-title":"Int J Cancer"},{"issue":"6","key":"953_CR74","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1210\/mend.13.6.0290","volume":"13","author":"CA Lange","year":"1999","unstructured":"Lange CA, Richer JK, Horwitz KB (1999) Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13(6):829\u2013836. https:\/\/doi.org\/10.1210\/mend.13.6.0290","journal-title":"Mol Endocrinol"},{"issue":"2","key":"953_CR75","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.canlet.2016.04.010","volume":"376","author":"O Lee","year":"2016","unstructured":"Lee O, Choi MR, Christov K, Ivancic D, Khan SA (2016) Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation. Cancer Lett 376(2):310\u2013317. https:\/\/doi.org\/10.1016\/j.canlet.2016.04.010","journal-title":"Cancer Lett"},{"issue":"4","key":"953_CR76","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/030089169307900403","volume":"79","author":"P Lissoni","year":"1993","unstructured":"Lissoni P, Barni S, Tancini G, Brivio F, Cardellini P, Vaghi M, Fossati V, Frigerio F (1993) Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapy. Tumori 79(4):246\u2013249","journal-title":"Tumori"},{"issue":"6","key":"953_CR77","first-page":"1317","volume":"27","author":"L Liu","year":"2010","unstructured":"Liu L, Shi G, Zhang Y, Lai Y, Liu Y, Lu X (2010) Effects of medroxyprogesterone acetate on endothelial progenitor cell. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(6):1317\u20131321","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"issue":"4","key":"953_CR78","first-page":"859","volume":"13","author":"L Magrassi","year":"1993","unstructured":"Magrassi L, Butti G, Silini E, Bono F, Paoletti P, Milanesi G (1993) The expression of genes of the steroid-thyroid hormone receptor superfamily in central nervous system tumors. Anticancer Res 13(4):859\u2013866","journal-title":"Anticancer Res"},{"issue":"2","key":"953_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0090-3019(88)90093-6","volume":"30","author":"TM Markwalder","year":"1988","unstructured":"Markwalder TM, Gerber HA, Waelti E, Schaffner T, Markwalder RV (1988) Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67. Surg Neurol 30(2):97\u2013101. https:\/\/doi.org\/10.1016\/0090-3019(88)90093-6","journal-title":"Surg Neurol"},{"issue":"1","key":"953_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0090-3019(87)90198-4","volume":"28","author":"TM Markwalder","year":"1987","unstructured":"Markwalder TM, Waelti E, K\u00f6nig MP (1987) Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols. Surg Neurol 28(1):3\u20139. https:\/\/doi.org\/10.1016\/0090-3019(87)90198-4","journal-title":"Surg Neurol"},{"issue":"10","key":"953_CR81","first-page":"1871","volume":"60","author":"C Martinoli","year":"1984","unstructured":"Martinoli C, Zocchi E, Querzola F, Damiani G, Zaccheo D (1984) Progesterone enhances reactive oxygen intermediates production by cultured human monocytes. Boll Soc Ital Biol Sper 60(10):1871\u20131877","journal-title":"Boll Soc Ital Biol Sper"},{"issue":"1","key":"953_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1385\/ENDO:8:1:65","volume":"8","author":"RC Melcangi","year":"1998","unstructured":"Melcangi RC, Cavarretta I, Magnaghi V, Ballabio M, Martini L, Motta M (1998) Crosstalk between normal and tumoral brain cells. Effect on sex steroid metabolism. Endocrine 8(1):65\u201371. https:\/\/doi.org\/10.1385\/ENDO:8:1:65","journal-title":"Endocrine"},{"issue":"12","key":"953_CR83","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1002\/j.1460-2075.1990.tb07613.x","volume":"9","author":"ME Meyer","year":"1990","unstructured":"Meyer ME, Pornon A, Ji JW, Bocquel MT, Chambon P, Gronemeyer H (1990) Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J 9(12):3923\u20133932","journal-title":"EMBO J"},{"issue":"1","key":"953_CR84","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1152\/physiolgenomics.00056.2011","volume":"44","author":"Y Misra","year":"2012","unstructured":"Misra Y, Bentley PA, Bond JP, Tighe S, Hunter T, Zhao FQ (2012) Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis. Physiol Genomics 44(1):76\u201388. https:\/\/doi.org\/10.1152\/physiolgenomics.00056.2011","journal-title":"Physiol Genomics"},{"issue":"4","key":"953_CR85","first-page":"1047","volume":"29","author":"BT Moe","year":"2009","unstructured":"Moe BT, Vereide AB, Orbo A, Jaeger R, Sager G (2009a) Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy. Anticancer Res 29(4):1047\u20131052","journal-title":"Anticancer Res"},{"issue":"4","key":"953_CR86","first-page":"1053","volume":"29","author":"BG Moe","year":"2009","unstructured":"Moe BG, Vereide AB, Orbo A, Sager G (2009b) High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis. Anticancer Res 29(4):1053\u20131058","journal-title":"Anticancer Res"},{"issue":"5","key":"953_CR87","first-page":"3045","volume":"22","author":"E Naglieri","year":"2002","unstructured":"Naglieri E, Lopez M, Lelli G, Morelli F, Amodio A, Di Tonno P, Gebbia N, Di Seri M, Chetri MC, Rizzo P, Abbate I, Casamassima A, Selvaggi FP, Colucci G (2002) Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma. Anticancer Res 22(5):3045\u20133051","journal-title":"Anticancer Res"},{"issue":"1\u20132","key":"953_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2011.10.030","volume":"357","author":"AE Obr","year":"2012","unstructured":"Obr AE, Edwards DP (2012) The biology of progesterone receptor in the normal mammary gland and in breast cancer. Mol Cell Endocrinol 357(1\u20132):4\u201317. https:\/\/doi.org\/10.1016\/j.mce.2011.10.030","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"953_CR89","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1189\/jlb.0207130","volume":"83","author":"Y Osorio","year":"2008","unstructured":"Osorio Y, Bonilla DL, Peniche AG, Melby PC, Travi BL (2008) Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production. J Leukoc Biol 83(6):1413\u20131422. https:\/\/doi.org\/10.1189\/jlb.0207130","journal-title":"J Leukoc Biol"},{"issue":"5","key":"953_CR90","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3171\/jns.1990.73.5.0736","volume":"73","author":"P Paoletti","year":"1990","unstructured":"Paoletti P, Butti G, Zibera C, Scerrati M, Gibelli N, Roselli R, Magrassi L, Sica G, Rossi G, Robustelli della Cuna G (1990) Characteristics and biological role of steroid hormone receptors in neuroepithelial tumors. J Neurosurg 73(5):736\u2013742. https:\/\/doi.org\/10.3171\/jns.1990.73.5.0736","journal-title":"J Neurosurg"},{"key":"953_CR91","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.steroids.2015.11.008","volume":"105","author":"AG Pi\u00f1a-Medina","year":"2016","unstructured":"Pi\u00f1a-Medina AG, Hansberg-Pastor V, Gonz\u00e1lez-Arenas A, Cerb\u00f3n M, Camacho-Arroyo I (2016) Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells. Steroids 105:19\u201325. https:\/\/doi.org\/10.1016\/j.steroids.2015.11.008","journal-title":"Steroids"},{"issue":"6","key":"953_CR92","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3171\/jns.1999.90.6.1072","volume":"90","author":"RJ Plunkett","year":"1999","unstructured":"Plunkett RJ, Lis A, Barone TA, Fronckowiak MD, Greenberg SJ (1999) Hormonal effects on glioblastoma multiforme in the nude rat model. J Neurosurg 90(6):1072\u20131077. https:\/\/doi.org\/10.3171\/jns.1999.90.6.1072","journal-title":"J Neurosurg"},{"issue":"3","key":"953_CR93","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00165601","volume":"1","author":"M Poisson","year":"1983","unstructured":"Poisson M, Pertuiset BF, Hauw JJ, Philippon J, Buge A, Moguilewsky M, Philibert D (1983) Steroid hormone receptors in human meningiomas, gliomas and brain metastases. J Neuro-Oncol 1(3):179\u2013189. https:\/\/doi.org\/10.1007\/BF00165601","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"953_CR94","first-page":"1627","volume":"19","author":"S Purmonen","year":"2008","unstructured":"Purmonen S, Manninen T, Pennanen P, Ylikomi T (2008) Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells. Oncol Rep 19(6):1627\u20131634","journal-title":"Oncol Rep"},{"issue":"7","key":"953_CR95","doi-asserted-by":"publisher","first-page":"e68695","DOI":"10.1371\/journal.pone.0068695","volume":"8","author":"ZY Qi","year":"2013","unstructured":"Qi ZY, Shao C, Zhang X, Hui GZ, Wang Z (2013) Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS One 8(7):e68695. https:\/\/doi.org\/10.1371\/journal.pone.0068695","journal-title":"PLoS One"},{"issue":"2A","key":"953_CR96","first-page":"1019","volume":"17","author":"BR Rao","year":"1997","unstructured":"Rao BR (1997) Pregnancy associated highly vascularized tumours negatively correlate with the levels of anti-angiogenic 17 alpha-hydroxy-progesterone. Anticancer Res 17(2A):1019\u20131021","journal-title":"Anticancer Res"},{"issue":"2","key":"953_CR97","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0010-7824(98)00067-5","volume":"58","author":"JR Reel","year":"1998","unstructured":"Reel JR, Hild-Petito S, Blye RP (1998) Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats. Contraception 58(2):129\u2013136. https:\/\/doi.org\/10.1016\/S0010-7824(98)00067-5","journal-title":"Contraception"},{"issue":"3\u20134","key":"953_CR98","first-page":"227","volume":"34","author":"M Riva","year":"1990","unstructured":"Riva M, Sterzi R, Canepari C, Erminio F, Bizzozzero L (1990) Prognostic relevance of hormonal and kinetic parameters in CNS neoplasms. J Neurosurg Sci 34(3\u20134):227\u2013230","journal-title":"J Neurosurg Sci"},{"issue":"2","key":"953_CR99","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archneur.1987.00520140069020","volume":"44","author":"NC Roelvink","year":"1987","unstructured":"Roelvink NC, Kamphorst W, van Alphen HA, Rao BR (1987) Pregnancy-related primary brain and spinal tumors. Arch Neurol 44(2):209\u2013215. https:\/\/doi.org\/10.1001\/archneur.1987.00520140069020","journal-title":"Arch Neurol"},{"issue":"1","key":"953_CR100","first-page":"189","volume":"28","author":"M Rosenthal","year":"1977","unstructured":"Rosenthal M (1977) Enhanced phagocytosis of immune complexes in pregnancy. Clin Exp Immunol 28(1):189\u2013191","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"953_CR101","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00003081-199606000-00024","volume":"39","author":"O Sartor","year":"1996","unstructured":"Sartor O, Cutler GB Jr (1996) Mifepristone: treatment of Cushing\u2019s syndrome. Clin Obstet Gynecol 39(2):506\u2013510. https:\/\/doi.org\/10.1097\/00003081-199606000-00024","journal-title":"Clin Obstet Gynecol"},{"key":"953_CR102","doi-asserted-by":"publisher","first-page":"e009","DOI":"10.1621\/nrs.07009","volume":"7","author":"KM Scarpin","year":"2009","unstructured":"Scarpin KM, Graham JD, Mote PA, Clarke CL (2009) Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl Recept Signal 7:e009. https:\/\/doi.org\/10.1621\/nrs.07009","journal-title":"Nucl Recept Signal"},{"issue":"2","key":"953_CR103","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P","volume":"82","author":"B Schlehofer","year":"1999","unstructured":"Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82(2):155\u2013160. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P","journal-title":"Int J Cancer"},{"key":"953_CR104","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3332\/ecancer.2013.381","volume":"7","author":"R Shao","year":"2013","unstructured":"Shao R (2013) Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma. Ecancermedicalscience 7:381. https:\/\/doi.org\/10.3332\/ecancer.2013.381","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"953_CR105","first-page":"373","volume":"59","author":"N Shinomiya","year":"1986","unstructured":"Shinomiya N, Tsuru S, Taniguchi M, Fujisawa H, Ikeda M, Zinnaka Y, Nomoto K (1986) Immune protective mechanisms during pregnancy. I. Cell-mediated immunity against Listeria monocytogenes in pregnant mice. Immunology 59(3):373\u2013378","journal-title":"Immunology"},{"issue":"1","key":"953_CR106","first-page":"71","volume":"33","author":"G Sica","year":"1989","unstructured":"Sica G, Zibera C, Ranelletti FO, Scerrati M, Butti G, Roselli R, Rossi GF, Robustelli Della Cuna G (1989) Some differences in steroid receptors between meningeal and neuroepithelial tumors. J Neurosurg Sci 33(1):71\u201375","journal-title":"J Neurosurg Sci"},{"issue":"5","key":"953_CR107","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/ijc.21467","volume":"118","author":"SA Silvera","year":"2006","unstructured":"Silvera SA, Miller AB, Rohan TE (2006) Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 118(5):1321\u20131324. https:\/\/doi.org\/10.1002\/ijc.21467","journal-title":"Int J Cancer"},{"issue":"1","key":"953_CR108","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.contraception.2006.03.016","volume":"74","author":"R Sitruk-Ware","year":"2006","unstructured":"Sitruk-Ware R (2006) Mifepristone and misoprostol sequential regimen side effects, complications and safety. Contraception 74(1):48\u201355. https:\/\/doi.org\/10.1016\/j.contraception.2006.03.016","journal-title":"Contraception"},{"issue":"6","key":"953_CR109","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1345\/aph.1P704","volume":"45","author":"SE Snow","year":"2011","unstructured":"Snow SE, Melillo SN, Jarvis CI (2011) Ulipristal acetate for emergency contraception. Ann Pharmacother 45(6):780\u2013786. https:\/\/doi.org\/10.1345\/aph.1P704","journal-title":"Ann Pharmacother"},{"issue":"1","key":"953_CR110","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/107155760200900102","volume":"9","author":"AK Sood","year":"2002","unstructured":"Sood AK, Fletcher MS, Hendrix MJ (2002) The embryonic-like properties of aggressive human tumor cells. J Soc Gynecol Investig 9(1):2\u20139. https:\/\/doi.org\/10.1177\/107155760200900102","journal-title":"J Soc Gynecol Investig"},{"issue":"5","key":"953_CR111","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/humrep\/15.5.1092","volume":"15","author":"P Stratton","year":"2000","unstructured":"Stratton P, Hartog B, Hajizadeh N, Piquion J, Sutherland D, Merino M, Lee YJ, Nieman LK (2000) A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women. Hum Reprod 15(5):1092\u20131099. https:\/\/doi.org\/10.1093\/humrep\/15.5.1092","journal-title":"Hum Reprod"},{"issue":"6","key":"953_CR112","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1095\/biolreprod57.6.1360","volume":"57","author":"L Tseng","year":"1997","unstructured":"Tseng L, Zhu HH (1997) Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells. Biol Reprod 57(6):1360\u20131366. https:\/\/doi.org\/10.1095\/biolreprod57.6.1360","journal-title":"Biol Reprod"},{"issue":"10","key":"953_CR113","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1210\/mend.7.10.8123133","volume":"7","author":"L Tung","year":"1993","unstructured":"Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB (1993) Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7(10):1256\u20131265. https:\/\/doi.org\/10.1210\/mend.7.10.8123133","journal-title":"Mol Endocrinol"},{"issue":"6","key":"953_CR114","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1046\/j.1365-2265.2003.01766.x","volume":"58","author":"H Utsunomiya","year":"2003","unstructured":"Utsunomiya H, Suzuki T, Ito K, Moriya T, Konno R, Sato S, Yaegashi N, Okamura K, Sasano H (2003) The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma. Clin Endocrinol 58(6):696\u2013703. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01766.x","journal-title":"Clin Endocrinol"},{"issue":"5","key":"953_CR115","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3171\/2009.8.JNS09201","volume":"112","author":"S Vadivelu","year":"2010","unstructured":"Vadivelu S, Sharer L, Schulder M (2010) Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. J Neurosurg 112(5):920\u2013924. https:\/\/doi.org\/10.3171\/2009.8.JNS09201","journal-title":"J Neurosurg"},{"issue":"12","key":"953_CR116","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/0959-8049(93)90122-V","volume":"29A","author":"HW Berg van den","year":"1993","unstructured":"van den Berg HW, Lynch M, Martin JH (1993) The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor. Eur J Cancer 29A(12):1771\u20131775","journal-title":"Eur J Cancer"},{"issue":"4","key":"953_CR117","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/1097-0142(19900215)65:4<949::AID-CNCR2820650421>3.0.CO;2-2","volume":"65","author":"E Schoultz von","year":"1990","unstructured":"von Schoultz E, Bixo M, B\u00e4ckstr\u00f6m T, Silfvenius H, Wilking N, Henriksson R (1990) Sex steroids in human brain tumors and breast cancer. Cancer 65(4):949\u2013952. https:\/\/doi.org\/10.1002\/1097-0142(19900215)65:4<949::AID-CNCR2820650421>3.0.CO;2-2","journal-title":"Cancer"},{"issue":"2","key":"953_CR118","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0090-3019(89)90318-2","volume":"31","author":"ER Waelti","year":"1989","unstructured":"Waelti ER, Markwalder TM (1989) Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture. Surg Neurol 31(2):96\u2013100. https:\/\/doi.org\/10.1016\/0090-3019(89)90318-2","journal-title":"Surg Neurol"},{"issue":"4","key":"953_CR119","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00002826-198412000-00021","volume":"7","author":"J Weidenfeld","year":"1984","unstructured":"Weidenfeld J, Schiller H (1984) Metabolism of steroids by human brain tumors. Clin Neuropharmacol 7(4):395\u2013397. https:\/\/doi.org\/10.1097\/00002826-198412000-00021","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"953_CR120","first-page":"616","volume":"118","author":"A Werner","year":"1996","unstructured":"Werner A, Aichberger A, Krebs D (1996) Does interferon-alpha enhance the effect of tamoxifen-medroxyprogesterone acetate and hydroxyflutamide on in vitro tumor cells? Zentralbl Gynakol 118(11):616\u2013621","journal-title":"Zentralbl Gynakol"},{"issue":"7","key":"953_CR121","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/aje\/kwj254","volume":"164","author":"A Wigertz","year":"2006","unstructured":"Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164(7):629\u2013636. https:\/\/doi.org\/10.1093\/aje\/kwj254","journal-title":"Am J Epidemiol"},{"issue":"1","key":"953_CR122","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2009.06.012","volume":"41","author":"AK Witkiewicz","year":"2010","unstructured":"Witkiewicz AK, McConnell T, Potoczek M, Emmons RV, Kurman RJ (2010) Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Hum Pathol 41(1):26\u201332. https:\/\/doi.org\/10.1016\/j.humpath.2009.06.012","journal-title":"Hum Pathol"},{"issue":"6","key":"953_CR123","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/PGP.0000000000000177","volume":"33","author":"RJ Zaino","year":"2014","unstructured":"Zaino RJ, Brady WE, Todd W, Leslie K, Fischer EG, Horowitz NS, Mannel RS, Walker JL, Ivanovic M, Duska LR (2014) Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study. Int J Gynecol Pathol 33(6):543\u2013553. https:\/\/doi.org\/10.1097\/PGP.0000000000000177","journal-title":"Int J Gynecol Pathol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-018-0953-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-018-0953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-018-0953-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T13:28:46Z","timestamp":1660483726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-018-0953-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s10143-018-0953-1","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not involve any human or animal experiments. Hence, no ethical approval or informed consent forms were needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}